We are pleased to invite investors and analysts to participate in our virtual event on Tuesday, 12 December 2023, highlighting Roche data presented at the 65th American Society of Hematology Annual Meeting and Exposition, from 9th to 12th December, 2023.   18:00 - 19:00 CET / 17:00 - 18:00 GMT 12:00 pm - 01:00 pm EST / 9:00 - 10:00 am PST   The webinar will start with presentations, followed by a Q&A session (live access to the speakers). The slides will be available for download at 17:00 CET on the day of the event. >click here   Agenda Welcome Bruno Eschli, Head of Investor Relations Roche hematology strategy Peter Ahnesorg, Franchise Head Hematology Review of key data presented at ASH Charles Fuchs, Senior Vice President - Global Head of Oncology and Hematology Product Development Q&A   Access to virtual event (pre-registration required) Please pre-register for our webinar here*.   Should you be unable to register for the webinar due to your company IT policy, please send an e-mail to investor.relations@roche.com.   A replay of the webcast will be available via > ir.roche.com   *privacy notice   Best regards,
Bruno Eschli Head of Investor Relations	Sabine Borngräber Investor Relations Officer

Roche Investor Relations
Dr. Bruno Eschli Phone: +41 61 68-75284 e-mail: bruno.eschli@roche.com	Dr. Sabine Borngräber Phone: +41 61 68-88027 e-mail: sabine.borngraeber@roche.com
Dr. Birgit Masjost Phone: +41 61 68-84814 e-mail: birgit.masjost@roche.com	Dr. Gerard Tobin Phone: +41 61 68-72942 e-mail: gerard.tobin@roche.com
Investor Relations North America
Loren Kalm Phone: +1 650 225 3217 e-mail: kalm.loren@gene.com

get the latest news and updates to your inbox.